Join Today & Get 4% Cash Back Then 6, 7...Up to 10% Off Reorders!

Online Pharmacy Dictionary

Find drugs by alphabetical list:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All

News on Iressa (gefitinib)

AstraZeneca's Iressa Drug A Valuable Option - IPASS Study - Wall Street Journal

AstraZeneca's Iressa Drug A Valuable Option - IPASS StudyWall Street JournalThe data was derived from the IRESSA Pan-Asia Study, or IPASS--a randomized, parallel-group investigation to assess the efficacy, safety and tolerability of ...ESMO: IPASS Data Show No Survival Benefit for GefitinibMedPage TodayErlotinib Trumps Chemo in Advanced NSCLC With EGFR MutationsInternal Medicine News Digital NetworkIressa as first line...Pharmacy EuropePharma Times�-Medscape�-TopNews United Kingdomall 79 news articles��

EGFR Mutations Give Survival Benefit in Lung Cancer - Medscape

MedscapeEGFR Mutations Give Survival Benefit in Lung CancerMedscapeFinal data from the Iressa Pan-Asia Study (IPASS) showed improved overall survival in patients with EGFR mutation-positive NSCLC, whether they receive ...and more��

AstraZeneca study highlights benefits of Iressa - Zenopa

AstraZeneca study highlights benefits of IressaZenopaAstraZeneca has published new clinical data which underlines the potential benefits of Iressa, its new treatment for lung cancer. The drug has been trialled ...

Tarceva May Improve Survival From Lung Cancer - WebMD

Biomed Middle EastTarceva May Improve Survival From Lung CancerWebMDA Japanese study reported earlier this year suggests that a similar drug, Iressa, may also be most effective if given prior to standard chemotherapy. ...Cancer data questions Roche, Lilly drugsFiercePharmaRoche drugs point to personalised lung cancer careReutersall 46 news articles��

Iressa (gefitinib)

Last updated on: Jan 24, 2007

What Is Iressa?

Iressa is a medicine used to kill cancer cells (chemotherapy). It is used alone for the continued treatment of patients who are benefiting or have benefited from Iressa. Iressa is approved for patients with non-small cell lung cancer (NSCLC) that:

has progressed after treatment with platinum based and docetaxel chemotherapies, or
did not respond to treatment with platinum based or docetaxel chemotherapies.

What Are The Risks?

The following are the major possible risks and side effects of Iressa therapy. This list is not complete.

Liver damage.
Eye problems, such as pain, redness or change in vision. Some patients have had an injury to the surface of the eye (cornea). This may be caused by eyelashes growing inside the eyelid.
Other side effects with Iressa may include: diarrhea, rash acne, dry skin, nausea, vomiting, itching, loss of appetite, weakness, weight loss

What Should I Tell My Healthcare Professional?

Before being treated with Iressa tell your healthcare professional if you:

have or had liver problems.
are trying to become pregnant, are already pregnant, or are breast-feeding

While being treated with Iressa call your healthcare professional right away if you develop:

severe or continual diarrhea, nausea, vomiting, or loss of appetite. These conditions can lead to low body fluids (dehydration).
an eye problem
any new symptoms

Are There Any Interactions With Drugs or Foods?

Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter drugs, and supplements. Especially tell your health care provider if you take: